EUVIMEDEUVIMED entdecken
Crossref

An Enzymatic in situ Self-Assembly Radiosensitizer for Hypoxic Tumor Radio-Immunotherapy via Low-Power X-ray-Induced Pyroptosis

Yuyang Tian iD, Yinxing Miao, Pengke Zhao, Lian Wang, Xiangdong He, Huiyu Chen, Zhiyuan Feng, Jinglang Gong, Xiaolian Sun iD, Jingjing Zhang iD, Ran Xie iD, Min Feng und 1 weitere

Journal of the American Chemical Society · 2026

DOI: 10.1021/jacs.6c13005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Yuyang Tian und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, Department of General Surgery, Nanjing Drum Tower Hospital, School of Chemistry, Chemi…. Hauptthemen laut MEDLINE: Pyroptosis, Radiation-Sensitizing Agents, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities, Joint Funds for the Innovation of Science and Technology in Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X-ray-induced cell pyroptosis represents a promising strategy for enhancing antitumor immunity. However, existing clinical radiosensitizers are hindered by inadequate tumor targeting and inefficiency in triggering pyroptosis, limiting the full potential of radioimmunotherapy. Herein, we introduce P–Ni-RGD, an enzymatically triggered in situ self-assembly radiosensitizer, as a pyroptosis inducer to improve cancer radioimmunotherapy. P–Ni-RGD incorporates an alkaline phosphatase (ALP)-responsive self-assembly scaffold, a cyclic RGD ligand, and a nitroimidazole (Ni) oxygen-mimetic radiosensitizer. Following systemic administration, P–Ni-RGD self-assembles into nanoparticles within the tumor microenvironment, specifically in response to ALP activation, enhancing tumor accumulation and enabling tumor-targeted delivery of the radiosensitizer and targeting ligand. In situ self-assembly results in the modulation of near-infrared fluorescence and photoacoustic bimodal imaging signals. Guided by these imaging modalities, low-dose X-ray irradiation (2 Gy) of orthotopic breast 4T1 tumors induces reactive oxygen species and promotes nitroreductase-mediated reduction of Ni to reactive intermediates within tumor cells. This cascade triggers the labeling of DNA repair proteins, upregulates key molecules involved in oxidative stress and DNA damage response, disrupts redox homeostasis, amplifies oxidative DNA damage, and impairs DNA repair. Accumulating DNA damage activates the AIM2 inflammasome, culminating in gasdermin D (GSDMD) dependent pyroptosis. This mechanism not only disrupts tumor cell viability but also provokes a potent antitumor immune response, significantly inhibiting primary and distant 4T1 tumors and prolonging survival. Our findings highlight the promise of combining enzymatic in situ self-assembly with low-dose X-rays to induce tumor-specific pyroptosis, offering an approach to enhance radiotherapeutic outcomes in hypoxic tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisRadiation-Sensitizing AgentsImmunotherapyAnimalsMiceX-RaysFemaleHumansCell Line, TumorNanoparticles

Substanzen

Radiation-Sensitizing Agents

Autor:innen und Institutionen

  • State Key Laboratory of Analytical Chemistry for Life Science, Department of General Surgery, Nanjing Drum Tower Hospital, School of Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University,…
  • State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing210009, China.

ORCID-Profile: Yuyang Tian, Xiaolian Sun, Jingjing Zhang, Ran Xie, Deju Ye

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Fundamental Research Funds for the Central Universities
  • Joint Funds for the Innovation of Science and Technology in Fujian Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Tian, Y., Miao, Y., Zhao, P., Wang, L., He, X., Chen, H., Feng, Z., Gong, J., Sun, X., Zhang, J., Xie, R., Feng, M., & Ye, D. (2026). An Enzymatic in situ Self-Assembly Radiosensitizer for Hypoxic Tumor Radio-Immunotherapy via Low-Power X-ray-Induced Pyroptosis. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c13005

Vancouver

Tian Y, Miao Y, Zhao P, Wang L, He X, Chen H, et al. An Enzymatic in situ Self-Assembly Radiosensitizer for Hypoxic Tumor Radio-Immunotherapy via Low-Power X-ray-Induced Pyroptosis. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c13005

BibTeX
@article{Tian2026,
  author = {Tian, Yuyang and Miao, Yinxing and Zhao, Pengke and Wang, Lian and He, Xiangdong and Chen, Huiyu and Feng, Zhiyuan and Gong, Jinglang and Sun, Xiaolian and Zhang, Jingjing and Xie, Ran and Feng, Min and Ye, Deju},
  title = {An Enzymatic in situ Self-Assembly Radiosensitizer for Hypoxic Tumor Radio-Immunotherapy via Low-Power X-ray-Induced Pyroptosis},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.6c13005}
}
Kostenlos starten →